Evaluating Novel and Relevant Information for Children's Health and Emotional Development

PUBLISHED RESEARCH

Aluminum

Mercury

Neuroligic and

Immune Development

Other Research

1. Empirical Data Confirm Autism Symptoms Related to Aluminum and Acetaminophen Exposure

 

2. Aluminum in the Central Nervous System

 

3. Aluminum and Vaccine Ingredients: What Do We Know? What Don’t We Know?

 

4. Aluminum Hydroxide Injections Lead to Motor Deficits and Motor Neuron Degeneration

 

5. Do Aluminum Vaccine Adjuvants Contribute to the Rising Prevalence of Autism?

 

6. Aluminum vaccine adjuvants: are they safe?

 

7. Protective effects of low-intensity pulsed ultrasound on aluminum-induced cerebral damage in Alzheimer’s disease rat model

 

8. Mechanisms of aluminum adjuvant toxicity and autoimmunity in pediatric populations

 

9. Aluminum hydroxide injections lead to motor deficits and motor neuron degeneration

 

10. Long-term persistence of vaccine-derived aluminum hydroxide is associated with chronic cognitive dysfunction

 

11. Long-term follow-up of cognitive dysfunction in patients with aluminum hydroxide-induced macrophagic myofasciitis (MMF)

 

12. Do aluminum vaccine adjuvants contribute to the rising prevalence of autism?

 

13. Aluminum adjuvant linked to gulf war illness induces motor neuron death in mice

 

14. Human exposure to aluminium

 

15. Aluminum Exposure at Human Dietary Levels for 60 Days Reaches a Threshold Sufficient to Promote Memory Impairment in Rats

 

16. Aluminum in the central nervous system (CNS): toxicity in humans and animals, vaccine adjuvants, and autoimmunity

 

17. The immunobiology of aluminium adjuvants: how do they really work?

 

18. Aluminum inclusion macrophagic myofasciitis: a recently identified condition

 

19. Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle

 

20. A role for the body burden of aluminium in vaccine-associated macrophagic myofasciitis and chronic fatigue syndrome

 

21. Aluminum as an adjuvant in Crohn’s disease induction

 

22. Aluminum is a potential environmental factor for Crohn's disease induction: extended hypothesis

 

23. DNA released from dying host cells mediates aluminum adjuvant activity

 

24. Mechanisms of aluminum adjuvant toxicity and autoimmunity in pediatric populations

 

25. Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity

 

26. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants

 

27. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells

 

28. Formulation of a killed whole cell pneumococcus vaccine - effect of aluminum adjuvants on the antibody and IL-17 response

 

29. Silica crystals and aluminum salts mediate NALP-3 inflammasome activation via phagosomal destabilization

 

30. Cutting Edge: Inflammasome activation by Alum and Alum’s adjuvant effect are mediated by NLRP3

 

31. Cognitive Deterioration and Associated Pathology Induced by Chronic Low-Level Aluminum Ingestion in a Translational Rat Model Provides an Explanation of Alzheimer's Disease, Tests for Susceptibility and Avenues for Treatment

 

32. Macrophagic myofasciitis: characterization and pathophysiology

 

33. Aluminum phagocytosis in quadriceps muscle following vaccination in children: relationship to macrophagic myofasciitis

1. B-Lymphocytes from a Population of Children with Autism Spectrum Disorder and Their Unaffected Siblings Exhibit Hypersensitivity to Thimerosal

 

2. Administration of Thimerosal to Infant Rats Increases Overflow of Glutamate and Aspartate in the Prefrontal Cortex: Protective Role of Dehydroepiandrosterone Sulfate

 

3. Comparison of blood and brain mercury levels in infant monkeys exposed to methylmercury or vaccines containing thimerosal

 

4. A case series of children with apparent mercury toxic encephalopathies manifesting with clinical symptoms of regressive autistic disorders

 

5. Neurodevelopmental disorders following thimerosal-containing childhood immunizations: a follow-up analysis

 

6. Persistent behavioral impairments and alterations of brain dopamine system after early postnatal administration of thimerosal in rats

 

7. Maternal thimerosal exposure results in aberrant cerebellar oxidative stress, thyroid hormone metabolism, and motor behavior in rat pups; sex- and strain-dependent effects

 

8. Neonatal administration of thimerosal causes persistent changes in mu opioid receptors in the rat brain

 

9. Integrating experimental (in vitro and in vivo) neurotoxicity studies of low-dose thimerosal relevant to vaccines

 

10. Administration of thimerosal to infant rats increases overflow of glutamate and aspartate in the prefrontal cortex: protective role of dehydroepiandrosterone sulfate

 

11. Activation of methionine synthase by insulin-like growth factor-1 and dopamine: a target for neurodevelopmental toxins and thimerosal

1. The Emerging Link Between Autoimmune Disorders and Neuropsychiatric Disease

 

2. Influence of pediatric vaccines on amygdala growth and opioid ligand binding in rhesus macaque infants: A pilot study

 

3. Primary Immunization of Premature Infants with Gestational Age <35 Weeks: Cardiorespiratory Complications and C-Reactive Protein Responses Associated with Administration of Single and Multiple Separate Vaccines Simultaneously

 

4. Neonatal administration of thimerosal causes persistent changes in mu opioid receptors in the rat brain.

 

5. Maternal thimerosal exposure results in aberrant cerebellar oxidative stress, thyroid hormone metabolism, and motor behavior in rat pups; sex- and strain-dependent effects.

 

6. Administration of thimerosal to infant rats increases overflow of glutamate and aspartate in the prefrontal cortex: protective role of dehydroepiandrosterone sulfate.

 

7. Abnormal measles-mumps-rubella antibodies and CNS autoimmunity in children with autism.

 

8. Integrating experimental (in vitro and in vivo) neurotoxicity studies of low-dose thimerosal relevant to vaccines.

 

9. Serological association of measles virus and human herpesvirus-6 with brain autoantibodies in autism.

 

10. In Harm’s Way: Toxic Threats to Child Development

 

11. Novel Roles for Immune Molecules in Neural Development: Implications for Neurodevelopmental Disorders

 

12. Immune Activation in Brain Aging and Neurodegeneration: Too Much or Too Little?

 

13. Primary Immunization of Premature Infants with Gestational Age <35 Weeks: Cardiorespiratory Complications and C-Reactive Protein Responses Associated with Administration of Single and Multiple Separate Vaccines Simultaneously

 

14. Neurodevelopmental disorders following thimerosal-containing childhood immunizations: a follow-up analysis.

 

15. Persistent behavioral impairments and alterations of brain dopamine system after early postnatal administration of thimerosal in rats.

 

16. Maternal thimerosal exposure results in aberrant cerebellar oxidative stress, thyroid hormone metabolism, and motor behavior in rat pups; sex- and strain-dependent effects.

 

17. Administration of thimerosal to infant rats increases overflow of glutamate and aspartate in the prefrontal cortex: protective role of dehydroepiandrosterone sulfate.

 

18. A possible central mechanism in autism spectrum disorders, part 1.

 

19. A possible central mechanism in autism spectrum disorders, part 2: immunoexcitotoxicity.

 

20. Association between vaccination and Guillain-Barré syndrome

 

21. Human papillomavirus vaccine and systemic lupus erythematosus

 

22. Autoimmune (Auto-inflammatory) Syndrome Induced by Adjuvants (ASIA) - Animal Models as a Proof of Concept

 

23. Hepatitis B Vaccination and Undifferentiated Connective Tissue Disease: Another Brick in the Wall of the Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA)

 

24. Effects of adjuvants for human use in systemic lupus erythematosus (SLE)-prone (New Zealand black/New Zealand white) F1 mice.

 

25. Vaccine-induced Autoimmunity

 

26. ‘ASIA’ - Autoimmune/inflammatory syndrome induced by adjuvants

 

27. The spectrum of ASIA: ‘Autoimmune (Auto-inflammatory) Syndrome induced by Adjuvants’

 

28. Chronic fatigue syndrome with autoantibodies--the result of an augmented adjuvant effect of hepatitis-B vaccine and silicone implant.

 

29. The Common Immunogenic Etiology of Chronic Fatigue Syndrome: From Infections to Vaccines via Adjuvants to the ASIA Syndrome

 

30. Guillain–Barré Syndrome—A Classical Autoimmune Disease Triggered by Infection or Vaccination

 

31. A Study of Molecular Mimicry and Immunological Cross-reactivity between Hepatitis B Surface Antigen and Myelin Mimics

 

32. Comparison of tissue reactions produced by Haemophilus pleuropneumoniae vaccines made with six different adjuvants in swine.

 

33. Induction of autoimmunity by pristane and other naturally-occurring hydrocarbons

 

34. Manifestations of systemic autoimmunity in vaccinated salmon

 

35. Polyclonal hypergammaglobulinemia and autoantibody production induced by vaccination in farmed Atlantic salmon.

 

36. Adjuvant immunization induces high levels of pathogenic antiphospholipid antibodies in genetically prone mice: another facet of the ASIA syndrome.

 

37. When APS (Hughes syndrome) met the autoimmune/inflammatory syndrome induced by adjuvants (ASIA).

 

38. Vaccine model of antiphospholipid syndrome induced by tetanus vaccine.

 

39. The sick building syndrome as a part of the autoimmune (auto-inflammatory) syndrome induced by adjuvants.

 

40. Gulf War syndrome as a part of the autoimmune (autoinflammatory) syndrome induced by adjuvant (ASIA).

 

41. Role of vaccinations as risk factors for ill health in veterans of the Gulf war: cross sectional study

 

42. Vaccination and systemic lupus erythematosus: the bidirectional dilemmas.

 

43. Human papilloma virus vaccine and primary ovarian failure: another facet of the autoimmune/inflammatory syndrome induced by adjuvants.

 

44. Postural tachycardia syndrome following human papillomavirus vaccination.

 

45. Guillain-Barré syndrome following hepatitis B vaccination

 

46. Pemphigus following hepatitis B vaccination--coincidence or causality?

 

47. Infection, vaccines and other environmental triggers of autoimmunity.

 

48. Fibromyalgia, infection and vaccination: two more parts in the etiological puzzle.

 

49. Anti-NMDA receptor encephalitis after TdaP-IPV booster vaccination: cause or coincidence?

 

50. Post-vaccination encephalomyelitis: Literature review and illustrative case

 

51. Interindividual variations in the efficacy and toxicity of vaccines.

 

52. Autoimmunity following hepatitis B vaccine as part of the spectrum of 'Autoimmune (Auto-inflammatory) Syndrome induced by Adjuvants' (ASIA): analysis of 93 cases.

 

53. Infection and vaccination in chronic fatigue syndrome: myth or reality?

 

54. Status epilepticus and lymphocytic pneumonitis following hepatitis B vaccination.

 

55. Post-influenza vaccination vasculitides: a possible new entity.

 

56. Vaccination, atherosclerosis and systemic lupus erythematosus.

 

57. Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine.

 

58. Vaccination of patients with auto-immune inflammatory rheumatic diseases requires careful benefit-risk assessment.

Miller's Review of Critical Vaccine Studies: 400 Important Scientific Papers Summarized for Parents and Researchers

 

Neil Z. Miller

In light of the discovery of Autoimmune Syndrome Induced by Adjuvants, or ASIA, Vaccines and Autoimmunity explores the role of adjuvants – specifically aluminum in different vaccines – and how they can induce diverse autoimmune clinical manifestations in genetically prone individuals.